Asepsis-Medical-Logo-WebAsepsis-Logo-Mobile
  • Home
  • Products
  • News
  • Inquires
    • Contact Us
    • Partnering with Asepsis
  • Company
    • Message from the CEO
    • Leadership Team
    • Patent Grants
    • Incidence of Medical Errors
    • Corporate Responsibility
    • Quality Compliance
    • Terms of Use
  • Home
  • Products
  • News
  • Inquires
    • Contact Us
    • Partnering with Asepsis
  • Company
    • Message from the CEO
    • Leadership Team
    • Patent Grants
    • Incidence of Medical Errors
    • Corporate Responsibility
    • Quality Compliance
    • Terms of Use
Asepsis-Logo-Mobile
  • Home
  • Products
  • News
  • Inquires
    • Contact Us
    • Partnering with Asepsis
  • Company
    • Message from the CEO
    • Leadership Team
    • Patent Grants
    • Incidence of Medical Errors
    • Corporate Responsibility
    • Quality Compliance
    • Terms of Use
  • Home
  • Products
  • News
  • Inquires
    • Contact Us
    • Partnering with Asepsis
  • Company
    • Message from the CEO
    • Leadership Team
    • Patent Grants
    • Incidence of Medical Errors
    • Corporate Responsibility
    • Quality Compliance
    • Terms of Use

Category "News"

May 11, 2022

Asepsis Announces The Grant Of Mexico Patent No. 384,129

Asepsis Medical Technologies® is proud to introduce the latest addition to the Calibrated Drug Delivery™ (CCD) platform, the Multi-Dose Safe-2-Dose® syringe. The Multi-Dose Safe-2-

CONTINUE READING
September 17, 2021

Asepsis Announces the Grant of Canadian Patent No. 3,006,218

Asepsis Medical Technologies® is proud to announce their latest Canadian Patent Grant 3,006,218 of August 24, 2021 – for the multi-dose oral Dose-2-Weight Syringe®. The Dose-2-Weight Sy

CONTINUE READING
July 26, 2021

Asepsis announces the US Patent Grant 11,058,606

Asepsis Medical Technologies announces the USPTO issuance of Patent Application Number 11,058,606 for its Safe-T-Fuse™ drug infusion system. The Safe-T-Fuse™ is an industry unique infusion contai

CONTINUE READING
July 21, 2021

Asepsis Announces the Grant of Mexico Patent MX/a/2017/012034

The Safe-T-Syringe® is designed to deliver the highest standard of patient care via syringe. Its medication calibrated indicia provide enhanced accuracy, convenience and safety through-out preparation

CONTINUE READING
February 2, 2021

Asepsis Announces the Grant of U.S. Patent 10,857,299

Asepsis Medical Technologies® is proud to introduce the latest addition to the Calibrated Drug Delivery™ (CCD) platform, the Multi-Dose Safe-2-Dose® syringe. The Multi-Dose Safe-2-Dose® syringe provid

CONTINUE READING
May 21, 2020

Asepsis Announces the U.S. Patent Grant No. 10,625,026

Asepsis Medical Technologies announces the U.S. Patent Grant for the Momenta-Dose™ forcé actuated injection device. The Momenta Dose™ is designed to administer rapid small volume subcutaneous or intra

CONTINUE READING
September 22, 2019

Asepsis Announces the Safe-2-Dose Integrated Dosing Container

Asepsis announces the patent pending Safe-2-Dose™, the next generation liquid medication dispenser. The caregiver need only unlock the device and squeeze the bottle to obtain the correct amount of med

CONTINUE READING
February 6, 2019

Asepsis Announces Australian Patent Acceptance No. 2018232988

Asepsis Medical Technologies announces the Australian Patent Acceptance No. 2018232988 for a suction and/or pressure inducing oral medication dosing applicator. The applicator comprising multiple dosi

CONTINUE READING
August 2, 2018

Asepsis announces the USPTO Notice of Allowance for its second Patent Application for the Safe-T-Fuse™

Asepsis Medical Technologies announces the USPTO issuance of Patent Application Number 15/255,725 for its Safe-T-Fuse™ drug infusion system. The Safe-T-Fuse™ is an industry unique infusion container t

CONTINUE READING
May 2, 2018

Asepsis announces the USPTO Notice of Allowance for Patent Application No. 14/877,349

Asepsis announces the USPTO Notice of Allowance for Patent Application No. 14/877,349 encompassing the prefilled and ready to fill, Diluent-2-Dose™ syringe. Read More… U.S. Patented Application 1

CONTINUE READING
1 2 3 4

Copyright © 2023 Asepsis Medical Technologies, LLC. All rights reserved.